Protara Therapeutics, Inc. Common Stock (TARA) is a publicly traded Healthcare sector company. As of August 11, 2026, TARA trades at $3.95 with a market cap of $231.56M and a P/E ratio of -3.04. TARA moved -3.16% today. Year to date, TARA is -22.89%; over the trailing twelve months it is +31.31%. Its 52-week range spans $2.77 to $7.82. Analyst consensus is strong buy with an average price target of $26.00. Rallies surfaces TARA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks TARA insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $3.95 |
| Market Cap | $231.56M |
| P/E Ratio | -3.04 |
| EPS | $-1.34 |
| Dividend Yield | 0.00% |
| 52-Week High | $7.82 |
| 52-Week Low | $2.77 |
| Volume | 76.80K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-57.44M |
| Gross Margin | 0.00% |
7 analysts cover TARA: 0 strong buy, 7 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $26.00.